Bradycardia — acute approach
Bedside summary
A structured approach to a slow heart rate (< 60/min, or inappropriately slow for the clinical state). SINUS BRADYCARDIA is common and often PHYSIOLOGICAL (athletes, sleep, high vagal tone) and asymptomatic — but bradycardia becomes an emergency when it causes ADVERSE FEATURES (shock/hypotension, syncope, myocardial ischaemia, heart failure) or reflects HIGH-RISK conduction disease (Mobitz II or complete AV block). As with tachyarrhythmia, the first branch is STABLE vs UNSTABLE, and the crucial parallel decision is whether the rhythm is a benign sinus slowing or a dangerous block that needs pacing. Always hunt the CAUSE.
Red flags
- Adverse features — shock, syncope, myocardial ischaemia, heart failure
- Mobitz II or COMPLETE (third-degree) AV block, or recent asystole/pauses — pacing indication
- Bradycardia with inferior STEMI, or with hyperkalaemia/drug toxicity
- Failure to respond to atropine — escalate to pacing
Assessment
Differential diagnosis
- Sinus bradycardia — physiological (athlete/sleep/vagal) or pathological
- AV block: first-degree, Mobitz I (Wenckebach), MOBITZ II, complete (third-degree) — see the specific protocols
- Junctional/nodal bradycardia; sick sinus / tachy-brady syndrome
- Secondary causes: drugs (beta-blocker, calcium-channel blocker, digoxin, amiodarone), inferior ischaemia/MI, hypothyroidism, hypothermia, raised ICP, hyperkalaemia/electrolytes, hypoxia, sepsis
Investigations
- 12-lead ECG (define sinus vs AV block and the level of block) with continuous monitoring
- Electrolytes (K⁺, Ca²⁺), glucose, TFTs, troponin if ischaemic; review the DRUG chart (rate-limiting agents, digoxin)
- Look for reversible causes — ischaemia (esp. inferior MI), hypothyroidism, hypothermia, hyperkalaemia, raised ICP, hypoxia
- Assess haemodynamics; get defibrillator/pacing pads to the bedside for high-risk block
Management
- ABCDE, oxygen if hypoxic, IV access, monitor and attach pacing pads. Decide STABLE vs UNSTABLE by adverse features (shock, syncope, ischaemia, heart failure).
- UNSTABLE or symptomatic → ATROPINE 500 mcg IV, repeat to a max of 3 mg; treat reversible causes (stop AV-nodal blockers, correct K⁺, give calcium/insulin-dextrose for hyperkalaemia, specific antidotes for drug toxicity).
- If atropine is ineffective or the block is HIGH-RISK (Mobitz II / complete block / recent asystole) → TRANSCUTANEOUS PACING and/or an isoprenaline or adrenaline infusion as a bridge, and arrange urgent TRANSVENOUS pacing.
- ASYMPTOMATIC sinus bradycardia with no adverse features usually needs only observation and treating the cause (review drugs, thyroid) — not atropine or pacing.
- Refer to cardiology for permanent pacing where indicated (e.g. Mobitz II, complete heart block, symptomatic sick sinus not due to a reversible cause).
Drugs & doses
Disposition
Complications & pitfalls
- Haemodynamic collapse, syncope and injury; asystole
- End-organ hypoperfusion (cardiac, cerebral, renal)
- Progression of high-grade block to complete heart block
Exam pearls
- STABLE vs UNSTABLE first — asymptomatic sinus bradycardia is often physiological and needs no treatment; treat the patient, not the number.
- Atropine works on VAGAL/nodal slowing but is often INEFFECTIVE in infranodal block (Mobitz II / complete) — go early to pacing there.
- Always review the drug chart and check potassium, thyroid, temperature and for inferior ischaemia — many bradycardias are reversible.
- Mobitz II and complete heart block need pacing even when symptoms are mild (see their protocols).
- Get pacing pads on early for any high-risk block rather than waiting for collapse.
Approach bradycardia by STABLE vs UNSTABLE and by SINUS-vs-BLOCK: asymptomatic sinus bradycardia is often physiological and just needs observation and treating the cause; symptomatic/unstable bradycardia gets atropine (to 3 mg) and reversible-cause treatment, escalating to transcutaneous → transvenous pacing (with isoprenaline/adrenaline as a bridge) — especially for atropine-resistant or high-risk block (Mobitz II/complete). Refer for permanent pacing when indicated. See the specific AV-block and sinus-node protocols for detail.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.